These were my thoughts as well when I seen the results for the rescue medication. It is possible to adjust for these differences, so maybe PAR should run their own analyses on the data to see if that's the case and release the results to the market if positive. I also note PAR has yet to release any findings from the exploratory analyses they've been performing in the background.
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-230
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $81.36M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $132.4K | 570.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 174687 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 63529 | 6 |
View Market Depth
| Last trade - 14.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |